Shares of DocGo Inc. (NASDAQ:DCGO – Get Rating) have earned an average rating of “Buy” from the eight ratings firms that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $14.00.
A number of brokerages have recently issued reports on DCGO. Canaccord Genuity Group reduced their price objective on shares of DocGo from $13.00 to $10.00 in a report on Wednesday, May 11th. Needham & Company LLC reiterated a “buy” rating and set a $14.00 price objective on shares of DocGo in a report on Wednesday, May 18th. Zacks Investment Research upgraded shares of DocGo from a “sell” rating to a “hold” rating in a report on Monday. Finally, Deutsche Bank Aktiengesellschaft started coverage on shares of DocGo in a report on Tuesday, April 19th. They set a “buy” rating and a $11.00 price objective for the company.
Hedge funds have recently made changes to their positions in the business. Royal Bank of Canada raised its position in DocGo by 226.3% in the first quarter. Royal Bank of Canada now owns 3,263 shares of the company’s stock worth $30,000 after acquiring an additional 2,263 shares during the period. Evoke Wealth LLC bought a new stake in DocGo in the fourth quarter worth about $47,000. Penserra Capital Management LLC bought a new stake in DocGo in the fourth quarter worth about $50,000. Lazard Asset Management LLC bought a new stake in shares of DocGo in the fourth quarter valued at approximately $50,000. Finally, Walleye Capital LLC bought a new stake in shares of DocGo in the first quarter valued at approximately $96,000. 16.03% of the stock is currently owned by institutional investors and hedge funds.
DocGo (NASDAQ:DCGO – Get Rating) last posted its quarterly earnings results on Monday, May 9th. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.04. The company had revenue of $117.89 million during the quarter, compared to the consensus estimate of $108.09 million. On average, research analysts forecast that DocGo will post 0.25 EPS for the current fiscal year.
DocGo Company Profile (Get Rating)
DocGo, Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
- Get a free copy of the StockNews.com research report on DocGo (DCGO)
- Should Medtronic Make the Cut For Your Recovery Watchlist?
- It’s Time To Nibble On These Two Recent IPOs
- Oil Markets On Track For New All-Time Highs
- Workday Gets Worked Over By The Analysts
- MarketBeat Podcast: Where Are The Next Small Cap Opportunities?
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.